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ABSTRACT: Finding new methods of carbon−carbon bond
formation is a key goal in expanding current methodology for
heterocycle formation. Because of their inherently nonplanar
shape, new methods of forming sp3-rich scaﬀolds are of
particular importance. Although there are methods for
combining heterocyclization and formation of new sp3−sp3 carbon−carbon bonds, these form the carbon−heteroatom bond
rather than a carbon−carbon bond of the heterocycle. Here, we show a new alkene arylallylation reaction that generates a
heterocycle with concomitant formation of two new carbon−carbon bonds. Furthermore, we demonstrate that this process
occurs through an isohypsic (redox neutral) mechanism. Overall, this carboallylation reaction gives a new route to the synthesis
of 3,3-disubstituted heterocycles.
1. INTRODUCTION
Heterocycles are found in a vast array of biologically active
molecules and complex natural products. Consequently, many
synthetic strategies have evolved to access these motifs.1
Palladium-catalyzed methods are among the most widely used,
due to the versatility and functional group tolerance of these
cycles.2 Most Pd-catalyzed heterocycle forming reactions take
advantage of the nucleophilicity of the heteroatom as a key
feature of the overall process. For example, we have previously
shown that difunctionalisation of alkenes by heteroallylation
can be used to generate a range of O- and N-containing
heterocycles (Figure 1a).3 A lesser-used set of reactions utilizes
starting materials where the carbon−heteroatom bonds are
already in place.4 For example, Pd-promoted cyclization of aryl
bromide 3, followed by Sonogashira−type coupling aﬀords
oxindole 4 (Figure 1b).5
The inclusion of more sp3-hybridized carbons in medicinal
chemistry programmes has been shown to correlate to
increased clinical success.6 As a complement to our earlier
alkene heteroallylation work that generates heterocycles
substituted with a new C(sp3)−C(sp3) bond at the 2 position
(Figure 1a), we became interested in developing a Pd-
catalyzed synthesis of 3,3-disubstituted heterocycles with
accompanying C(sp3)−C(sp3) bond formation (Figure 1c).
The success of this transformation would provide a new
potential strategy to access complex biologically active
compounds, such as the nM norepinephrine reuptake inhibitor
daledalin, or the neurokinin receptor antagonist 7 (Figure 2).7
A single literature report describes Pd-catalyzed heterocycle
synthesis from aryl boronic acids (8 → 9, Scheme 1).8 This
process likely proceeds through a Pd(0)−Pd(II) catalytic cycle,
including β-hydride elimination and reoxidation of the Pd by
oxygen. On the basis of this precedent as well as our experience
on developing an isohypsic (redox neutral) heteroallylation of
alkenes (Figure 1a), we set out to develop an alkene
carboallylation reaction that would generate 3,3-disubstituted
heterocycles with concomitant sp3−sp3 C−C bond formation
(Figure 1c).
2. RESULTS AND DISCUSSION
2.1. Optimization. An initial attempt at carboallylation was
carried out using conditions similar to the heteroallylation
(Table 1). Pleasingly, this resulted in formation of the desired
dihydrobenzofuran 11, albeit as a minor component, with the
main products being that of direct allylation 12 and
deboronation 13 (entry 1). A change of the allyl halide from
bromide to chloride resulted in decreased formation of the
deboronation product 13 (entry 2). Lowering the number of
the equivalents of allyl chloride caused an improvement in the
ratio of 11:12, although the formation of 13 was also increased
(entries 3 and 4). Continuing with 2 equivalents of allyl
chloride, the eﬀect of the catalyst system was examined (Table
2). The use of phosphine ligands proved detrimental, with
none of the desired product formed (entries 2 and 3).
Palladium(II) catalyst PdCl2 led to the slightly decreased
formation of the desired product, along with lower formation
of deboronation product 13 (entry 4), whereas palladium(0)
catalysts did not result in formation of the desired product
(entries 5−7). The use of phosphonite catalyst 149 resulted in
an improved ratio between the desired and direct coupling
products, but use of this catalyst was discontinued because of
the formation of several additional unidentiﬁed side products
(entry 8).
Moving from an aqueous base to a solid base greatly
improved the ratio between 11:12 (Table 3, entries 1 and 2).
Use of other solid bases, such as sodium hydroxide or cesium
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ﬂuoride, caused lower or zero conversion to the desired
product (entries 3 and 4). Use of organic bases, such as
triethylamine, also resulted in formation of the desired product
as a minor component (entry 5).
Next, the choice of solvent was examined (Table 4). Use of
dimethylformamide (DMF) showed no conversion to the
desired product, with the only product being that of direct
allylation (entry 2). Acetonitrile and tetrahydrofuran (THF)
not only lowered the formation of the deboronated product
but also resulted in the formation of less desired product
(entries 3 and 4). Use of dimethoxyethane completely
suppressed the formation of the deboronated product,
although overall conversion was lowered (entry 5).
Carrying these conditions forward, the choice of boron
reagent was examined (Table 5). Pinacol boronate ester
proved ineﬀective, with only a small amount of the desired
product formed, with direct allylation product 12 being the
major result (entry 2). N-methyliminodiacetic acid (MIDA)
boronate showed very low conversion, with the only product
formed that of direct allylation (entry 3). Potassium
Figure 1. Examples of Pd-catalyzed heterocycle formation and our plan for a new synthesis of 3,3-disubstituted heterocycles.
Figure 2. Biologically active 3,3-disubstituted heterocycles.
Scheme 1. Heterocyclization of Boronic Acid 8
Table 1. Eﬀect of Allyl Halide Equivalents on Product Ratios
entry X equiv. 10 11 12 13
1 Br 5 0 0.1 1 1.2
2 Cl 5 0.2 0.1 1 0.3
3 Cl 2 0.1 0.3 1 0.7
4 Cl 1.1 0 0.4 1 0.9
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triﬂuoroborate 15, however, gave full conversion of the starting
material while maintaining the ratio of desired/direct allylated
products, forming the desired dihydrobenzofuran in 48%
isolated yield (entry 4).
2.2. Reaction Scope. As the competition between desired
11 and direct coupling 12 products involves a cyclization step,
the “reactive rotomer” eﬀect10 can have an important inﬂuence
on product ratio (Scheme 2). After transmetallation to form
Pd(II) intermediate 16, the proximity of the O-methallyl chain
determines how easily direct coupling or cyclization can occur.
For cyclization to occur, the O-methallyl chain must be in close
proximity to the Pd(II). As it is less sterically favorable for the
O-methallyl chain to be close to the Pd(II) (conformer 16′), it
will likely spend more time at a greater distance (conformer
17). This leaves the Pd(II) intermediate 16 more vulnerable to
direct coupling. By replacing the hydrogen in the 3-position
with another group, orientation of the O-methallyl chain
toward the 3-position should become less favorable. This
should result in the equilibrium being displaced toward 16′,
therefore favoring cyclization.
To this end, the carboallylation conditions were applied to
methyl-substituted potassium triﬂuoroborate 18 (Scheme 3).
As predicted, the formation of direct allylation product 20 was
greatly suppressed, with only a trace amount detected. The
Table 2. Eﬀect of Palladium-Catalyst System
entry Pd source additive 10 11 12 13
1 Pd(hfacac)2 0.1 0.3 1 0.7
2 Pd(hfacac)2 PPh3 (1 equiv.) 0 0 1 0.2
3 Pd(hfacac)2 PPh3 (2 equiv.) 0.3 0 1 0
4 PdCl2 0 0.2 1 0.1
5 PdCl2(dppf) 0.3 0 1 0.1
6 Pd(OAc)2 0 0 1 0.2
7 Pd2dba3 0 0 1 0
8a 14 0 0.7 1 0.1
aIn addition to 11 and 13, several additional side products were observed by 1H NMR.
Table 3. Eﬀect of Base
entry base 10 11 12 13
1 Na2CO3 (2 M aq.) 0.1 0.3 1 0.7
2 Na2CO3
a 3.2 6.7 1 10
3 NaOHa 0 0.1 1 0.2
4 CsFa 0 0 1 0.2
5 NEt3 0.1 0.3 1 3.1
aBases used as solids.
Table 4. Eﬀect of Solvent
entry solvent 10 11 12 13
1 toluene 3.2 6.7 1 10
2 DMF 0 0 1 0
3 MeCN 2.4 1.1 1 3.3
4 THF 3.6 1.4 1 0.7
5 DME 9.2 3.4 1 0
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desired dihydrobenzofuran 19 was formed in 46% isolated
yield.
During the development of their palladium-catalyzed
cyclization of aryl halides, Zhou et al. also observed
competition between cyclization and direct alkynylation.5
The direct alkynylation process could be largely suppressed
by using N-methylmethacrylamides, as shown in Figure 1b. We
thus employed N-methylmethacrylamide 22 (Scheme 4) as a
boron analog of the aryl halide substrates used by Zhou et al.
Pleasingly, the carboallylation conditions were successfully
resulted in formation of oxindoline 23 in 47% yield, with only
trace amounts of direct allylation product 24 formed.
2.3. Mechanistic Study. To examine the mechanism of
the arylallylation process, a deuterium-labeling study was
carried out. The heterocycle formation was carried out using
aryltriﬂuoroborate 15 using dideuteroallyl bromide (Scheme
Table 5. Eﬀect of Boronic Acid Source
entry B 10 11 12 13
1 B(OH)2 9.2 3.4 1 0
2 BPin 0 0.1 1 0
3 BMIDA 8.8 0 1 0
4 BF3K 0 3.5
a 1 0.2
a48% isolated yield.
Scheme 2. Reactive Rotomer Eﬀect on Carboallylation
Scheme 3. Carboallylation of Methyl-Substituted 18
Scheme 4. Carboallylation of Methylmethacrylamide 22
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5). This resulted in the formation of dihydrobenzofuran 25 as
a single deuterated isomer, and direct allylation products 26a
and 26b as a 1:1 mixture of deuterated isomers (in 21 and 1%
isolated yields, respectively).
This is consistent with an isohypsic mechanism for the
formation of 25 (Scheme 6). Beginning with transmetallation
of boronic acid 10, palladium(II) intermediate 16 is formed.
Carbopalladation (oleﬁn insertion) forms the C−C bond of
the dihydrobenzofuran ring, giving 27. A second carbopalla-
dation can then occur, this time onto the allyl halide double
bond giving palladium(II) intermediate 28. Finally, β-halide
elimination gives the dihydrobenzofuran product 25 as a single
deuterated isomer, and releases the palladium(II) catalyst.
However, an isohypsic mechanism is not consistent with the
formation of a 1:1 mixture of deuterated isomers of the direct
allylation products 26a/b. This suggests that the direct
allylation products are formed via an alternative mechanism.
Beginning with oxidative addition of palladium(0) into the allyl
halide, π-allyl palladium(II) species 29a/b are formed (Scheme
7). Transmetallation of boronic acid 10 gives rise to
palladium(II) intermediates 30a/b. Finally, reductive elimi-
nation forms the direct allylated products 26a/b and reforms
the palladium(0) catalyst.
As the dihydrobenzofuran and direct allylation products
appear to be formed by separate mechanisms, it should be
possible to control, which product is formed by controlling the
catalyst used. Having already shown the use of a palladium(II)
catalyst to form a dihydrobenzofuran product from potassium
triﬂuoroborate 15 (Table 5, entry 4), we chose to treat 15 with
a Pd(0) catalyst. As predicted, exposure of 15 to Pd2dba3 and
allyl chloride resulted in the sole formation of direct coupling
product 12 (Scheme 8).11 Interestingly, use of several common
oxidants, such as benzoquinone, DDQ, O2, or Cu(II), did not
favor the isohypsic cyclization process.
3. CONCLUSIONS
We have developed a new Pd-catalyzed arylallylation reaction
of alkenes. This reaction has been demonstrated in the
formation of heterocycles, such as dihydrobenzofurans and
oxindolines, results in formation of two new carbon−carbon
bonds, and generates a quaternary carbon center. After
elimination of the deboronation side product and suppression
of the direct coupling product, the arylallylation reaction was
Scheme 5. Product Distribution of Carboallylation Using Deuterium-Labeled Allyl Bromide
Scheme 6. Proposed Mechanism for the Formation of 25
Scheme 7. Proposed Mechanism for the Formation of 26a/b
Scheme 8. Selective Formation of Direct Coupling Product
12
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shown to proceed through an isohypsic palladium(II)-
catalyzed mechanism. By controlling the reaction conditions,
selective formation of either the cyclized or direct allylated
product is possible.
4. EXPERIMENTAL SECTION
4.1. 2-(2-Methylallyloxy)phenylboronic Acid (10).
Following a literature procedure,12 to a stirred suspension of
2-iodophenol (12 g, 52 mmol) and potassium carbonate (14 g,
110 mmol) in DMF (260 mL), was added methallyl chloride
(6.1 mL, 63 mmol). The reaction mixture was heated at 70 °C
for 16 h, and then cooled to room temperature (RT), diluted
with EtOAc (250 mL), and the phases were separated. The
organic phase was washed with water (100 mL) and brine (3 ×
100 mL), dried (MgSO4), ﬁltered, and concentrated in vacuo
to give 1-(2-methylallyloxy)-2-iodobenzene as a yellow oil (14
g, quant.). Analytical data were in accordance with literature
values.13
Following a literature procedure,14 to a stirred solution of 1-
(2-methylallyloxy)-2-iodobenzene (12 g, 43 mmol) and
triisopropyl borate (12 mL, 52 mmol) in toluene/THF (4:1)
(160 mL) at −78 °C, was added nBuLi (26 mL, 52 mmol).
The reaction mixture was stirred at −78 °C for 1 h and then
allowed to warm to −20 °C and quenched with 2 M aq. HCl
(100 mL). The mixture was allowed to warm to room
temperature and then extracted with Et2O (2 × 50 mL). The
combined organic extracts were washed with brine, dried
(MgSO4), ﬁltered, and concentrated in vacuo. Puriﬁcation by
ﬂash chromatography (petroleum ether/EtOAc, 9:1 to 4:1)
gave a pale yellow solid, which was boiled in water for 2 h.
After cooling, the mixture was ﬁltered to give the title
compound 10 as a pale yellow crystalline solid (4.2 g, 51%).
Analytical data were in accordance with literature values.14
4.2. Potassium (2-(2-Methylallyloxy)phenyl)-
triﬂuoroborate (15). Following a literature procedure,15 to
a stirred solution of 2-(2-methylallyloxy)phenylboronic acid 10
(0.50 g, 2.6 mmol) in acetonitrile (11 mL), was added a
solution of KF (0.60 g, 10 mmol) in water (1.2 mL). A
solution of (L)-tartaric acid (0.80 g, 5.3 mmol) in THF (4.0
mL) was then added to the rapidly stirring solution, and a
white precipitate was observed immediately. The reaction
mixture was stirred rapidly for 30 min, and then the precipitate
was removed by ﬁltration, and washed with acetonitrile. The
ﬁltrate was concentrated in vacuo to give the title compound
15 as a ﬂuﬀy white solid (0.63 g, 95%).
1H NMR (400 MHz, DMSO-d6) δ (ppm): 7.29 (1H, dd, J =
7.1, 1.9 Hz, Ar−H), 6.96 (1H, ddd, J = 8.0, 7.2, 2.0 Hz, Ar−
H), 6.66 (1H, t, J = 7.2 Hz, Ar−H), 6.62 (1H, d, J = 8.1 Hz,
Ar−H), 5.16−5.14 (1H, m, CCHa), 4.85−4.84 (1H, m,
CCHb), 4.27 (2H, s, OCH2), 1.76 (3H, s, CH3); 13C NMR
(125 MHz, DMSO) δ (ppm): 161.6 (C), 142.1 (C), 138.7 (C,
observed indirectly by heteronuclear multiple bond correlation
(HMBC)), 133.4 (q, 3J(C−F) = 3.1 Hz, CH), 126.3 (CH),
119.1 (CH), 110.99 (CH), 110.97 (CH2), 70.5 (CH2), 19.3
(CH3); IR (solid) 1597, 1437, 1209, 1188, 922 cm
−1; high-
resolution mass spectrometry (HRMS) (ESI) exact mass
calculated for C10H11F3OB [M − K]− m/z 214.0897, found m/
z 214.0858.
4 . 3 . Po t a s s i um (2 - ( 2 -Me thy l a l l y l o xy ) - 3 -
methylphenyl)triﬂuoroborate (18). Following a literature
procedure,12 to a stirred suspension of 6-bromo-o-cresol (0.66
mL, 5.4 mmol) and potassium carbonate (1.5 g, 11 mmol) in
DMF (30 mL), was added methallyl chloride (0.62 mL, 6.4
mmol). The reaction mixture was heated at 70 °C for 16 h, and
then cooled to room temperature, diluted with EtOAc (30
mL), and separated. The organic phase was washed with water
(20 mL) and brine (3 × 20 mL), dried (MgSO4), ﬁltered, and
concentrated in vacuo to give 2-(2-methylallyl)-3-bromoto-
luene as a yellow oil (1.3 g, quant.).
1H NMR (500 MHz, CDCl3) δ (ppm): 7.38 (1H, dd, J =
8.0, 1.5 Hz, Ar−H), 7.12 (1H, dq, J = 7.6, 0.7 Hz, Ar−H), 6.89
(1H, t, J = 7.8 Hz, Ar−H), 5.19−5.18 (1H, m, CCHa),
5.02−5.01 (1H, m, CCHb), 4.31 (2H, s, OCH2), 2.33 (3H,
s, CH3), 1.93 (3H, d, J = 0.4 Hz, CH3);
13C NMR (125 MHz,
CDCl3) δ (ppm): 154.4 (C), 141.4 (C), 133.6 (CH), 131.2
(CH), 130.5 (C), 125.3 (CH), 117.7 (C), 113.1 (CH2), 76.2
(CH2), 19.9 (CH3), 16.8 (CH3); IR (thin ﬁlm) 2920, 1653,
1464, 1452, 1260, 1220 cm−1; HRMS (EI) exact mass
calculated for C11H13OBr [M]
+ m/z 240.0150, found m/z
240.0153.
Following a literature procedure,14 to a stirred solution of 2-
(2-methylallyl)-3-bromotoluene (0.79 g, 3.3 mmol) and
triisopropyl borate (0.90 mL, 3.9 mmol) in toluene/THF
(4:1) (14 mL) at −78 °C was added nBuLi (1.8 mL, 3.9
mmol). The reaction mixture was stirred at −78 °C for 1 h,
and then allowed to warm to −20 °C, and quenched with 2 M
aq. HCl (10 mL). The mixture was allowed to warm to room
temperature and then extracted with Et2O (2 × 5 mL). The
combined organic extracts were washed with brine, dried
(MgSO4), ﬁltered, and concentrated in vacuo. Puriﬁcation by
ﬂash chromatography (petroleum ether/ethyl acetate, 9:1)
gave a pale yellow solid, which was boiled in water for 2 h.
After cooling, the mixture was ﬁltered to give 2-(2-
methylallyloxy)-3-methyl-phenylboronic acid as a pale yellow
crystalline solid (0.44 g, 66%).
1H NMR (400 MHz, CDCl3) δ (ppm): 7.68 (1H, dd, J =
7.2, 1.6 Hz, Ar−H), 7.31 (1H, ddt, J = 7.5, 1.9, 0.7 Hz, Ar−H),
7.11 (1H, t, J = 7.4 Hz, Ar−H), 6.04 (2H, s, B(OH)2), 5.23
(1H, s, CCHa), 5.05 (1H, s, CCHb), 4.23 (2H, s, OCH2),
2.31 (3H, s, CH3), 1.89 (3H, s, CH3);
13C NMR (125 MHz,
CDCl3) δ (ppm): 163.1 (C), 140.9 (C), 135.1 (CH), 134.3
(CH), 130.3 (C), 124.8 (CH), 123.0 (C, observed indirectly
by HMBC), 113.3 (CH2), 78.0 (CH2), 19.8 (CH3), 16.1
(CH3); IR (thin ﬁlm) 3412, 2910, 1464, 1435, 1383, 1344,
1084 cm−1; HRMS (CI) exact mass calculated for C11H15O3 B
[M]+ m/z 206.1229, found m/z 206.1232.
Following a literature procedure,15 to a stirred solution of 2-
(2-methylallyloxy)-3-methyl-phenylboronic acid (0.072 g, 0.35
mmol) in acetonitrile (1.4 mL), was added a solution of KF
(0.081 g, 1.4 mmol) in water (0.15 mL). A solution of (L)-
tartaric acid (0.11 g, 0.72 mmol) in THF (0.53 mL) was then
added to the rapidly stirring solution, and a white precipitate
was observed immediately. The reaction mixture was stirred
rapidly for 30 min, and then the precipitate was removed by
ﬁltration, and washed with acetonitrile. The ﬁltrate was
concentrated in vacuo to give the title compound 18 as a
ﬂuﬀy white solid (0.084 g, 89%).
1H NMR (400 MHz, DMSO) δ (ppm): 7.20 (1H, dd, J =
7.2, 1.9 Hz, Ar−H), 6.87 (1H, ddd, J = 7.2, 2.0, 0.8 Hz, Ar−
H), 6.73 (1H, t, J = 7.2 Hz, Ar−H), 5.05 (1H, dq, J = 2.4, 1.0
Hz, CCHa), 4.83 (1H, dq, J = 2.7, 1.3 Hz, CCHb), 4.23
(2H, s, OCH2), 2.12 (3H, s, CH3), 1.78 (3H, dd, J = 1.5, 0.8
Hz, CH3);
13C NMR (125 MHz, DMSO) δ (ppm): 160.6 (C),
143.3 (C), 142.0 (C, observed indirectly by HMBC), 132.0 (q,
3J(C−F) = 3.0 Hz, CH), 128.3 (CH), 128.2 (C), 121.8 (CH),
110.2 (CH2), 75.5 (CH2), 19.6 (CH3), 16.5 (CH3); IR (solid)
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1448, 1192, 993 cm−1; HRMS (ESI) exact mass calculated for
C11H13F3OB [M − K]− m/z 228.1053, found m/z 228.1034.
4.4. N,2-Dimethyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-di-
oxaborolan-2-yl)phenyl]-2-propenamide (22). Following
a modiﬁcation of a literature procedure,16 a mixture of
bromoaniline (0.11 mL, 1.0 mmol) and bis(pinacolato)-
diboron (0.38 g, 1.5 mmol) in dioxane (4 mL) was sparged
with argon for 20 min. Potassium acetate (0.20 g, 2.0 mmol)
and Pd(dppf)Cl2 (0.041 g, 0.050 mmol) were added, and the
reaction mixture was stirred at 80 °C. After 24 h,
bis(pinacolato)diboron (0.38 g, 1.5 mmol) was added, and
the reaction mixture was stirred at 80 °C for further 24 h. After
cooling to room temperature, water (10 mL) was added, and
the mixture was extracted with EtOAc (3 × 10 mL). The
combined organic extracts were washed with brine, dried
(MgSO4), ﬁltered, and concentrated in vacuo. Puriﬁcation by
ﬂash chromatography (petroleum ether/ethyl acetate, 96:4)
aﬀorded 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
as an orange crystalline solid (0.15 g, 67%). Analytical data
were in accordance with literature values.17
Following a literature procedure,17 to a stirred solution of 2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (0.10 g,
0.46 mmol) in toluene (15 mL) at 0 °C, was added
triethylamine (0.50 mL, 0.46 mmol, 0.90 M) in toluene. A
solution of methacryloyl chloride (0.50 mL, 0.46 mmol, 0.9 M)
in toluene was added slowly (0.2 mL/min). The reaction
mixture was stirred at 0 °C for 20 min and then allowed to
warm to room temperature. The reaction mixture was washed
with water (2 × 20 mL), dried (MgSO4), ﬁltered, and
concentrated in vacuo. Puriﬁcation by ﬂash chromatography
(petroleum ether/ethyl acetate, 85:15) aﬀorded 2-methyl-N-
[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-pro-
penamide as a light brown crystalline solid (90 mg, 69%).
Analytical data were in accordance with literature values.17
Following a literature procedure, to a stirred suspension of
2-methyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
phenyl]-2-propenamide (0.73 g, 2.5 mmol) and potassium
carbonate (0.40 g, 2.9 mmol) in DMF (41 mL), was added
methyl iodide (0.22 mL, 3.6 mmol). The reaction mixture was
stirred at room temperature overnight, diluted with EtOAc
(100 mL) and water (100 mL), and extracted. The organic
phase was washed with water (2 × 100 mL) and brine (3 ×
100 mL), dried (MgSO4), ﬁltered, and concentrated in vacuo.
Puriﬁcation by ﬂash chromatography (petroleum ether/ethyl
acetate, 4:1) aﬀorded the title compound 22 as an orange
crystalline solid (0.47 g, 62%).
1H NMR (500 MHz, DMSO-d6, 80 °C) δ (ppm): 7.69 (1H,
dd, J = 7.4, 1.7 Hz, Ar−H), 7.48 (1H, td, J = 7.7, 1.7 Hz, Ar−
H), 7.31 (1H, td, J = 7.4, 1.1 Hz, Ar−H), 7.19 (1H, dd, J = 8.0,
1.1 Hz, Ar−H), 4.99 (2H, s, CCH2), 3.20 (3H, s, NCH3),
1.73 (3H, s, CCH3), 1.29 (12H, s, 4 × CCH3);
13C NMR (125
MHz, DMSO-d6, 80 °C) δ (ppm): 169.7 (C), 140.3 (C), 136.0
(C), 135.3 (CH), 132.5 (CH), 131.3 (C), 128.6 (CH), 126.2
(CH), 116.8 (CH2), 82.9 (C), 37.7 (CH3), 24.2 (CH3), 19.5
(CH3); IR (thin ﬁlm) 2978, 1653, 1352, 1145 cm
−1; HRMS
(ESI) exact mass calculated for C17H24BNNaO3 [M + Na]
+ m/
z 324.1741, found m/z 324.1740.
4.5. 3-(But-3-en-1-yl)-3-methyl-2,3-dihydrobenzofur-
an (11). A screw-top glass vial (4 mL) was charged with
potassium (2-(2-methylallyloxy)phenyl)triﬂuoroborate 15 (76
mg, 0.30 mmol), Pd(hfacac)2 (16 mg, 0.030 mmol), Na2CO3
(64 mg, 0.60 mmol), dimethoxyethane (1.2 mL), and allyl
chloride (49 μL, 0.60 mmol), and the vial was sealed under
ambient atmosphere. The resulting mixture was heated to 50
°C by immersion of the entire vial into a preheated aluminum
block for 16 h. Puriﬁcation by ﬂash chromatography
(petroleum ether/dichloromethane, 9:1) aﬀorded the title
compound 11 as a colorless oil (27 mg, 48%).
1H NMR (400 MHz, CDCl3) δ (ppm): 7.15−7.07 (2H, m,
Ar−H), 6.88 (1H, td, J = 7.4, 1.0 Hz, Ar−H), 6.79 (1H, dt, J =
8.0, 0.5 Hz, Ar−H), 5.76 (1H, ddt, J = 16.7, 10.2, 6.4 Hz,
CHCH2), 4.98 (1H, dq, J = 17.1, 1.7 Hz, CHCHH),
4.94−4.90 (1H, m, CHCHH), 4.37 (1H, d, J = 8.7 Hz, O−
CHH), 4.16 (1H, d, J = 8.6 Hz, O−CHH), 2.15−2.05 (1H, m,
CH2CHHCHCH2), 1.92−1.82 (1H, m, CH2CHHCH
CH2), 1.73−1.68 (2H, m, CH2CH2CHCH2), 1.36 (3H, s,
CH3);
13C NMR (125 MHz, CDCl3) δ (ppm): 159.9 (C),
138.5 (CH), 135.0 (C), 128.2 (CH), 123.0 (CH), 120.6
(CH), 114.7 (CH2), 109.7 (CH), 82.6 (CH2), 45.3 (C), 40.2
(CH2), 29.2 (CH2), 25.7 (CH3); IR (thin ﬁlm) 2934, 1365,
1196 cm−1; HRMS (EI) exact mass calculated for C13H16O
[M]+ m/z 188.1201, found m/z 188.1203.
4.6. 3-(But-3-en-1-yl)-3-methyl-7-methyl-2,3-dihydro-
benzofuran (19). A screw-top glass vial (4 mL) was charged
with potassium (2-(2-methylallyloxy)-3-methylphenyl)-
triﬂuoroborate 18 (220 mg, 0.80 mmol), Pd(hfacac)2 (42
mg, 0.080 mmol), Na2CO3 (170 mg, 1.6 mmol), dimethoxy-
ethane (3.2 mL), and allyl chloride (0.13 mL, 1.6 mmol), and
the vial was sealed under ambient atmosphere. The resulting
mixture was heated to 50 °C by immersion of the entire vial
into a preheated aluminum block for 16 h. Puriﬁcation by ﬂash
chromatography (petroleum ether/dichloromethane, 9:1)
aﬀorded the title compound 19 as a colorless oil (74 mg, 46%).
1H NMR (500 MHz, CDCl3) δ (ppm): 6.96 (1H, dq, J =
7.4, 0.7 Hz, Ar−H), 6.92 (1H, dd, J = 7.4, 0.7 Hz, Ar−H), 6.80
(1H, t, J = 7.4 Hz, Ar−H), 5.75 (1H, ddt, J = 16.8, 10.2, 6.5
Hz, CHCH2), 4.99 (1H, dq, J = 17.1, 1.7 Hz, CHCHH),
4.93−4.91 (1H, m, CHCHH), 4.38 (1H, d, J = 8.7 Hz, O−
CHH), 4.17 (1H, d, J = 8.7 Hz, O−CHH), 2.22 (3H, s, CH3),
2.14−2.06 (1H, m, CH2CHHCHCH2), 1.91−1.84 (1H, m,
CH2CHHCHCH2), 1.75−1.65 (2H, m, CH2CH2CH
CH2), 1.35 (3H, s, CH3);
13C NMR (125 MHz, CDCl3) δ
(ppm): 158.0 (C), 138.6 (CH), 134.3 (C), 129.4 (CH), 120.5
(CH), 120.4 (CH), 119.9 (C), 114.6 (CH2), 82.4 (CH2), 45.6
(C), 40.2 (CH2), 29.2 (CH2), 25.7 (CH3), 15.2 (CH3); IR
(thin ﬁlm) 2965, 2922, 1456, 1188 cm−1; HRMS (EI) exact
mass calculated for C14H18O [M]
+ m/z 202.1358, found m/z
202.1357.
4.7. 3-(But-3-en-1-yl)-1,3-dimethylindolin-2-one (23).
A screw-top glass vial (4 mL) was charged with N,2-dimethyl-
N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-
propenamide 22 (22 mg, 0.080 mmol), Pd(hfacac)2 (4.2 mg,
0.0080 mmol), Na2CO3 (17 mg, 0.16 mmol), dimethoxy-
ethane (0.32 mL), and allyl chloride (13 μL, 0.16 mmol), and
the vial was sealed under ambient atmosphere. The resulting
mixture was heated to 50 °C by immersion of the entire vial
into a preheated aluminum block for 16 h. Puriﬁcation by ﬂash
chromatography (petroleum ether/ethyl acetate, 95:5) af-
forded the title compound 23 as a colorless oil (7.5 mg, 47%).
1H NMR (500 MHz, CDCl3) δ (ppm): 7.27 (1H, td, J = 7.7,
1.2 Hz, Ar−H), 7.17 (1H, dd, J = 7.3, 0.7 Hz, Ar−H), 7.07
(1H, td, J = 7.5, 0.8 Hz, Ar−H), 6.84 (1H, d, J = 7.8 Hz, Ar−
H), 5.68−5.60 (1H, m, CHCH2), 4.843−4.841 (1H, m,
CHCHH), 4.82−4.81 (1H, m, CHCHH), 3.20 (3H, s, N-
CH3), 2.05−2.00 (1H, m, CH2CHHCHCH2), 1.85−1.79
(1H, m, CH2CHHCHCH2), 1.77−1.69 (1H, m,
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CHHCH2CHCH2), 1.66−1.59 (1H, m, CHHCH2CH
CH2), 1.36 (3H, s, CH3);
13C NMR (125 MHz, CDCl3) δ
(ppm): 180.7 (C), 143.5 (C), 137.9 (CH), 134.0 (C), 127.9
(CH), 122.7 (CH), 122.6 (CH), 114.7 (CH2), 108.0 (CH),
48.3 (CH3), 37.7 (CH2), 29.1 (CH2), 26.2 (CH3); IR (thin
ﬁlm) 2974, 2929, 1705, 1614, 1379, 1352 cm−1; HRMS (EI)
exact mass calculated for C14H17ON [M]
+ m/z 215.1310,
found m/z 215.1311.
4.8. 3-(4,4-Dideuteriobut-3-en-1-yl)-3-methyl-2,3-di-
hydrobenzofuran (25). A screw-top glass vial (4 mL) was
charged with potassium (2-(2-methylallyloxy)phenyl)-
triﬂuoroborate 15 (64 mg, 0.25 mmol), Pd(hfacac)2 (13 mg,
0.025 mmol), Na2CO3 (53 mg, 0.50 mmol), dimethoxyethane
(1.0 mL), and dideuteroallyl bromide18 (0.37 mL, 1.3 M in
Et2O, 0.50 mmol), and the vial was sealed under ambient
atmosphere. The resulting mixture was heated to 50 °C by
immersion of the entire vial into a preheated aluminum block
for 16 h. Puriﬁcation by ﬂash chromatography (petroleum
ether/dichloromethane, 9:1) aﬀorded the title compound 25
as a colorless oil (8.8 mg, 19%).
1H NMR (400 MHz, CDCl3) δ (ppm): 7.13 (1H, ddd, J =
8.0, 7.4, 1.5 Hz, Ar−H), 7.08 (1H, ddd, J = 7.4, 1.5, 0.6 Hz,
Ar−H), 6.88 (1H, td, J = 7.4, 1.0 Hz, Ar−H), 6.79 (1H, ddd, J
= 8.0, 1.0, 0.5 Hz, Ar−H), 5.79−5.73 (1H, m, CHCD2),
4.38 (1H, d, J = 8.7 Hz, O−CHH), 4.17 (1H, d, J = 8.7 Hz,
O−CHH), 2.15−2.06 (1H, m, CHHCH2CHCD2), 1.92−
1.83 (1H, m, CHHCH2CHCD2), 1.73−1.69 (2H, m,
CH2CH2CHCD2), 1.36 (3H, s, CH3); 13C NMR (100
MHz, CDCl3) δ (ppm): 159.7 (C), 138.3 (CH), 135.0 (C),
128.2 (CH), 123.0 (CH), 120.6 (CH), 114.0 (t, 1J(C−D) =
24.1 Hz, CD2), 109.7 (CH), 82.6 (CH2), 45.3 (C), 40.2
(CH2), 29.1 (CH2), 25.7 (CH3); IR (thin ﬁlm) 2926, 2237,
1600, 1481 cm−1; HRMS (EI) exact mass calculated for
C13H14D2O [M]
+ m/z 190.1321, found m/z 190.1315.
4.9. 1-(Dideuterioallyl)-2-((2-methallyl)oxy)benzene
(26a/b). A screw-top glass vial (4 mL) was charged with
potassium (2-(2-methylallyloxy)phenyl)triﬂuoroborate 15 (64
mg, 0.25 mmol), Pd(hfacac)2 (13 mg, 0.025 mmol), Na2CO3
(53 mg, 0.50 mmol), dimethoxyethane (1.0 mL), and
dideuteroallyl bromide18 (0.37 mL, 1.3 M in Et2O, 0.50
mmol), and the vial was sealed under ambient atmosphere.
The resulting mixture was heated to 50 °C by immersion of the
entire vial into a preheated aluminum block for 16 h.
Puriﬁcation by ﬂash chromatography (petroleum ether/
dichloromethane, 9:1) aﬀorded the title compounds in a 1:1
mixture as a colorless oil (1 mg, 1%).
1H NMR (400 MHz, CDCl3) δ (ppm): 7.19−7.14 (2H, m,
Ar−H), 6.90 (1H, t, J = 7.4, Ar−H), 6.83 (1H, d, J = 8.1, Ar−
H), 6.04−5.97 (1H, m, CHCD2/CHCH2), 5.11 (1H, s,
OCH2CCHa), 5.09−5.02 (2H, m, CD2CCH2), 4.98 (1H,
s, OCH2CCHb), 4.43 (2H, s, OCH2), 3.43 (2H, d, J = 6.6
Hz, CH2CCD2), 1.84 (3H, s, CH3); 13C NMR (100 MHz,
CDCl3) δ (ppm): 159.7 (C), 138.3 (CH), 135.0 (C), 128.2
(CH), 123.0 (CH), 120.6 (CH), 114.0 (t, 1J(C−D) = 24.1 Hz,
CD2), 109.7 (CH), 82.6 (CH2), 45.3 (C), 40.2 (CH2), 29.1
(CH2), 25.7 (CH3); IR (thin ﬁlm) 2926, 2237, 1600, 1481
cm−1; HRMS (EI) exact mass calculated for C13H14D2O [M]
+
m/z 190.1321, found m/z 190.1315.
4.10. 2-(2-Methylallyloxy)phenylboronic acid pinacol
ester. Following a modiﬁcation of the reported procedure,19 a
mixture of 2-(2-methylallyloxy)phenylboronic acid 10 (500
mg, 2.6 mmol) and pinacol (307 mg, 2.6 mmol) in Et2O (15
mL) was stirred at room temperature (RT) for 17 h and then
heated at reﬂux for 4 h. The mixture was cooled to RT and
washed with brine (3 × 25 mL). The organic extracts were
dried (Na2SO4), ﬁltered, and concentrated in vacuo. The
1H
NMR spectrum of the crude material indicated approximately
80% conversion, so the residue was reﬂuxed with pinacol (92
mg, 0.8 mmol) in Et2O (15 mL) for 16 h. The cooled reaction
mixture was washed with water (25 mL), brine (2 × 25 mL),
dried (Na2SO4), ﬁltered, and concentrated in vacuo to aﬀord
the title compound as a colorless oil (650 mg, 92%).
1H NMR (500 MHz, CDCl3) δ (ppm): 7.68 (1H, dd, J =
7.3, 1.8 Hz, 6-H), 7.37 (1H, ddd, J = 8.8, 6.9, 1.4 Hz, 4-H),
6.94 (1H, td, J = 7.3, 0.8 Hz, 5-H), 6.84 (1H, d, J = 8.3 Hz, 3-
H), 5.34−5.35 (1H, m, CCHa), 4.97−4.98 (1H, m, C
CHb), 4.42 (2H, s, OCH2), 1.86 (3H, s, CH3), 1.35 (12H, s, 2
× C(CH3)2);
13C NMR (125 MHz, CDCl3) δ (ppm): 163.4
(C), 141.1 (C), 136.9 (CH), 132.6 (CH), 120.4 (CH), 118.4
(C, observed indirectly by HMBC), 111.9 (CH2), 111.6 (CH),
83.5 (2 × C), 71.6 (CH2), 25.1 (4 × CH3), 19.6 (CH3); IR
(thin ﬁlm) 1670, 1438, 1300, 1246, 1196, 1142; HRMS (ESI)
exact mass calculated for C16H23NaO3B [M + Na]
+ m/z
296.1669, found m/z 296.1664.
4.11. 2-(2-Methylallyloxy)phenylboronic Acid Meth-
yliminodiacetic Acid Ester. Following a modiﬁcation of the
reported procedure,20 to a solution of 2-(2-methylallyloxy)-
phenylboronic acid 10 (86 mg, 0.50 mmol) in DMF (1.5 mL),
was added methylimindodiacetic acid (74 mg, 0.50 mmol).
The resulting suspension was heated at 85 °C for 24 h and
then ﬁltered through an Isolute Si-Carbonate cartridge (500
mg), rinsing with MeCN. The ﬁltrate was concentrated in
vacuo and then partitioned between EtOAc (15 mL) and water
(15 mL). The organic extracts were washed with brine (15
mL), dried (Na2SO4), ﬁltered, and concentrated in vacuo.
Puriﬁcation by ﬂash chromatography (petroleum ether/
EtOAc, 1:2 then 0:1) aﬀorded the title compound as a
colorless foam (100 mg, 66%).
1H NMR (500 MHz, CDCl3) δ (ppm): 7.69 (1H, dd, J =
7.4, 3.5 Hz, 6-H), 7.34 (1H, ddd, J = 8.2, 7.4, 1.8 Hz, 4-H),
6.99 (1H, td, J = 7.3, 0.8 Hz, 5-H), 6.87 (1H, d, J = 8.2 Hz, 3-
H), 5.02 (2H, s, CCH2), 4.46 (2H, s, OCH2), 3.96 (4H, s,
CH2N(CH3)CH2), 2.71 (3H, s, NCH3), 1.80 (3H, s,
C(CH3)CH2); 13C NMR (125 MHz, CDCl3) δ (ppm):
168.0 (2 × C), 161.7 (C), 141.2 (C), 135.3 (CH), 131.5
(CH), 123.3 (C, observed indirectly by HMBC), 121.5 (CH),
114.3 (CH2), 111.9 (CH), 72.7 (CH2), 63.9 (2 × CH2), 47.5
(CH3), 19.7 (CH3); IR (solid) 1746, 1311, 1208, 1035, 1000;
HRMS (ESI) exact mass calculated for C15H18NNaO5B [M +
Na]+ m/z 325.1207, found m/z 325.1195.
4.12. 1-Allyl-2-((2-methylallyl)oxy)benzene (12). 1H
NMR (500 MHz, CDCl3) δ (ppm): 7.19−7.16 (2H, m, 4-H,
6-H), 6.91 (1H, td, J = 7.4, 1.0 Hz, 5-H), 6.85 (1H, d, J = 8.1
Hz, 3-H), 6.07−5.98 (1H, m, CH2CHCH2), 5.13 (1H, s,
C(CH3)CHa), 5.10−5.03 (2H, m, CH2CHCH2), 4.99
(1H, s, C(CH3)CHb), 4.44 (2H, s, OCH2), 3.44 (2H, d, J =
6.7 Hz, CH2CHCH2), 1.85 (3H, s, C(CH3)CH2); 13C
NMR (125 MHz, CDCl3) δ (ppm): 156.4 (C), 141.2 (C),
137.2 (CH), 129.9 (CH), 129.0 (C), 127.3 (CH), 120.7
(CH), 115.5 (CH2), 112.3 (CH2), 111.6 (CH), 71.7 (CH2),
34.6 (CH2), 19.6 (CH3); IR (thin ﬁlm) 1491, 1451, 1238;
HRMS (EI) exact mass calculated for C13H16O [M]
+ m/z
188.1201, found m/z 188.1997.
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